Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom
Antibiotics · 22.01.2025 · 14 (2) · 114
DOI: 10.3390/antibiotics14020114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 22.01.2025. Verfasst von Daniela I Munteanu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Ninewells Hospital, Dundee DD1 9SY, UK. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tayside Health Fund, National Laboratory of Biotechnology, Hungary, European Union's Horizon 2020 Research and Innovation Programme.
Abstract (Originalsprache)
Background
Bacteriophages (phages) are viruses that infect and kill bacteria. The antimicrobial resistance crisis has driven renewed interest in phage therapy, including the use of phages to treat chronic orthopaedic infections.
Methods
Here, we present the results of the first three orthopaedic patients treated with phage therapy in the United Kingdom.
Results
The first patient was treated in May 2023 and received phages active against Staphylococcus aureus. At nine months follow-up, the patient’s wound remained healed, the C-reactive protein normal and the patient was walking independently. The second patient received phages active against Klebsiella pneumoniae and S. aureus; the infection remained unresolved. The third patient received phages active against Staphylococcus epidermidis; at six months follow-up, the patient was free of infection. Endotoxin was considered at least partially responsible for mild self-limiting adverse effects in two cases.
Conclusions
These promising results hint at the potential for phage therapy to transform the care of chronic orthopaedic infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology, Ninewells Hospital, Dundee DD1 9SY, UK.
- Pharmacy Department, Ninewells Hospital, Dundee DD1 9SY, UK.
- Synthetic and Systems Biology Unit, Institute of Biochemistry, National Laboratory of Biotechnology, HUN-REN Biological Research Centre, Temesvári Krt. 62, 6726 Szeged, Hungary.
- HCEMM-BRC Translational Microbiology Research Group, Budapesti út 9, 6728 Szeged, Hungary.
- Laboratory of Molecular and Cellular Technology, Queen Astrid Military Hospital, Bruynstraat 1, 1120 Brussels, Belgium.
- Center for Infectious Diseases ID4C, Queen Astrid Military Hospital, Bruynstraat 1, 1120 Brussels, Belgium.
ORCID-Profile: Gábor Apjok, Maya Merabishvili, Jean-Paul Pirnay, Matjaž Peterka, Emily A Simpson, Samantha Downie, Alasdair MacInnes, Joshua D Jones
Förderung
- Tayside Health Fund
- National Laboratory of Biotechnology, Hungary
- European Union's Horizon 2020 Research and Innovation Programme
- Slovenian Research Agency
- Royal Higher Institute of Defence, Belgium
- National Laboratory of Biotechnology
- European Union’s Horizon 2020 Research and Innovation Programme
Zitieren
APA
Munteanu, D. I., Dunn, J., Apjok, G., Kintses, B., Griselain, J., Steurs, G., Cochez, C., Djebara, S., Merabishvili, M., Pirnay, J. P., Štilec, V., Peterka, M., Simpson, E. A., Downie, S., MacInnes, A., Nicol, G., Clift, B., & Jones, J. D. (2025). Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom. Antibiotics, 14(2), 114. https://doi.org/10.3390/antibiotics14020114
Vancouver
Munteanu DI, Dunn J, Apjok G, Kintses B, Griselain J, Steurs G, et al. Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom. Antibiotics. 2025;14(2):114. doi:10.3390/antibiotics14020114
BibTeX
@article{Munteanu2025,
author = {Munteanu, Daniela I and Dunn, John and Apjok, Gábor and Kintses, Bálint and Griselain, Johann and Steurs, Griet and Cochez, Christel and Djebara, Sarah and Merabishvili, Maya and Pirnay, Jean-Paul and Štilec, Vida and Peterka, Matjaž and Simpson, Emily A and Downie, Samantha and MacInnes, Alasdair and Nicol, Graeme and Clift, Benedict and Jones, Joshua D},
title = {Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {2},
pages = {114},
doi = {10.3390/antibiotics14020114}
}
EUVIMED